1. Home
  2. CODX vs GURE Comparison

CODX vs GURE Comparison

Compare CODX & GURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CODX
  • GURE
  • Stock Information
  • Founded
  • CODX 2013
  • GURE 2006
  • Country
  • CODX United States
  • GURE China
  • Employees
  • CODX N/A
  • GURE N/A
  • Industry
  • CODX Medical/Dental Instruments
  • GURE Major Chemicals
  • Sector
  • CODX Health Care
  • GURE Industrials
  • Exchange
  • CODX Nasdaq
  • GURE Nasdaq
  • Market Cap
  • CODX 9.8M
  • GURE 8.5M
  • IPO Year
  • CODX 2017
  • GURE 1992
  • Fundamental
  • Price
  • CODX $0.28
  • GURE $0.68
  • Analyst Decision
  • CODX Buy
  • GURE
  • Analyst Count
  • CODX 2
  • GURE 0
  • Target Price
  • CODX $5.50
  • GURE N/A
  • AVG Volume (30 Days)
  • CODX 1.1M
  • GURE 636.1K
  • Earning Date
  • CODX 08-07-2025
  • GURE 05-13-2025
  • Dividend Yield
  • CODX N/A
  • GURE N/A
  • EPS Growth
  • CODX N/A
  • GURE N/A
  • EPS
  • CODX N/A
  • GURE N/A
  • Revenue
  • CODX $3,497,583.00
  • GURE $7,958,395.00
  • Revenue This Year
  • CODX N/A
  • GURE N/A
  • Revenue Next Year
  • CODX $42.11
  • GURE N/A
  • P/E Ratio
  • CODX N/A
  • GURE N/A
  • Revenue Growth
  • CODX N/A
  • GURE N/A
  • 52 Week Low
  • CODX $0.23
  • GURE $0.50
  • 52 Week High
  • CODX $2.23
  • GURE $1.47
  • Technical
  • Relative Strength Index (RSI)
  • CODX 51.71
  • GURE 47.64
  • Support Level
  • CODX $0.26
  • GURE $0.64
  • Resistance Level
  • CODX $0.29
  • GURE $0.75
  • Average True Range (ATR)
  • CODX 0.02
  • GURE 0.05
  • MACD
  • CODX 0.00
  • GURE -0.01
  • Stochastic Oscillator
  • CODX 64.83
  • GURE 29.55

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

About GURE Gulf Resources Inc. (NV)

Gulf Resources Inc is a holding company engaged in the manufacture and trade of bromine and crude salt, and natural gas; manufactures and sells chemical products used in oil and gas field exploration, oil and gas distribution, oil field drilling, wastewater processing, papermaking chemical agents and inorganic chemicals, and manufactures and sells materials for human and animal antibiotics. It operates in four segments: Bromine, Crude Salt, Chemical Products and Natural Gas. It derives maximum revenue from the Bromine segment which is commonly used in brominated flame retardants, fumigants, water purification compounds, dyes, medicines and disinfectants.

Share on Social Networks: